FocusLeishmaniasis

Using Humans to Make a Human Leishmaniasis Vaccine

See allHide authors and affiliations

Science Translational Medicine  30 Apr 2014:
Vol. 6, Issue 234, pp. 234fs18
DOI: 10.1126/scitranslmed.3009118

You are currently viewing the abstract.

View Full Text

Log in to view the full text

Log in through your institution

Log in through your institution

Abstract

The cellular immune response to peptide pools from conserved Leishmania antigens in leishmaniasis-immune individuals identified epitopes for a human DNA vaccine (Das et al., this issue).

View Full Text